http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010525884-A

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-1654
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-013
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-1613
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-16
filingDate 2008-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2010-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2010525884-A
titleOfInvention Intraocular lens with peripheral area designed to reduce negative abnormal optical vision
abstract In one aspect, the present invention provides an intraocular lens (IOL) that includes an optical element (12) and a peripheral optical flange (14) surrounding the optical element. The optical element forms a field image on the retina of the IOL user, and the peripheral optical flange suppresses abnormal photovision. As an example, the peripheral optical flange includes at least one textured surface that receives ambient rays incident on the eye at a large viewing angle and scatters those ambient rays, for example, Abnormal photovision by inhibiting the formation of secondary images or by scattering some light into shadow areas between such secondary images and the image formed by the IOL Suppress.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013511369-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016530933-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015522383-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013118176-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013118499-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7088589-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021153381-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9563070-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2021153381-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2013118499-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015504691-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9658471-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021152815-A1
priorityDate 2007-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID77066
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422600808
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID4111
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415761642
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415762110
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID4111
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16130922
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID77260

Total number of triples: 34.